Upregulation of heparanase, the mammalian endoglycosidase devoted to HS degradation, is observed in essentially all tumor types examined, including carcinomas, sarcomas, and hematological malignancies where, in several cases, it is associated with an aggressive tumor behavior [49,51,54]. This evidence concerns the gene HPSE and neoplasm.